Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: A cohort analysis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Miro, Jose M ^a   Manzardo, Christian ^a   Mussini, Cristina ^b   Johnson, Margaret ^c   d'Arminio Monforte, Antonella ^d   Antinori, Andrea ^e   Gill, M John ^f   Sighinolfi, Laura ^g   Uberti Foppa, Caterina ^h   Borghi, Vanni ^b   Sabin, Caroline ⁱ  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d SAN PAOLO HOSPITAL   (Italy)

^e NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^f Southern Alberta Clinic   (Canada)

^g S ANNA HOSPITAL   (Italy)

^h VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY INTERVENTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NONHUMAN; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUBERCULOSIS; VIRUS LOAD; ADULT; CANADA; EUROPE; EVALUATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE AGED; RISK FACTOR; SURVIVAL; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANADA; COHORT STUDIES; DISEASE PROGRESSION; EUROPE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 80054726992     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026009     Document Type: Article

References (22)

1. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, et al. (2003) Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med 138 (8): 620-626.
2. Antiretroviral therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372 (9635): 293-299.
3. Girardi E, Sabin CA, Monforte AD, (2007) Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 46 (Suppl 1): S3-S8.
4. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, et al. (2004) Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 18 (16): 2145-2151.
5. Hocking JS, Rodger AJ, Rhodes DG, Crofts N, (2000) Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis: characteristics of individuals. Int J STD AIDS 11 (8): 503-508.
6. Schwarcz S, Hsu L, Dilley JW, Loeb L, Nelson K, et al. (2006) Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. J Acquir Immune Defic Syndr 43 (4): 491-494.
7. Sobrino Vegas P, García San Miguel L, Caro-Murillo AM, Miró JM, Viciana P, et al. (2009) Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to cART and impact on mortality. Current HIV Research 7 (2): 224-230.
8. Mussini C, Manzardo C, Johnson M, Monforte A, Uberti-Foppa C, et al. (2008) Patients presenting with AIDS in the HAART era: A collaborative cohort analysis. AIDS 22 (18): 2461-69.
9. French MA, (2007) Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Current HIV/AIDS Reports 4 (1): 16-21.
10. Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, et al. (2010) Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection. PLoS ONE 5 (7): e11416.
11. Manzardo C, Zaccarelli M, Agüero F, Antinori A, Miró JM, (2007) Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease. J Acquir Immune Defic Syndr 2007; 46 (Suppl 1): S9-S18.
12. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, et al. (2009) Antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 4 (5): e5575.
13. Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, et al. (2010) Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis 50 (11): 1532-1538.
14. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362 (8): 697-706.
15. Abdool Karim SS, Naidoo K, Padayatchi N, Grobler A, Baxter C, et al. Optimal timing of ART during TB therapy: Findings of the SAPiT Trial. 18th Conference on Retroviruses and Opportunistic Infections, February 27-March 2, 2011, Boston, MA, USA. Abstract n. 39LB.
16. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. (2010) Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis. XVIII International AIDS Conference (IAS). Vienna, July 18-23, 2010. Abstract THLBB106.
17. Havlir D, Ive P, Kendall M, Luetkemeyer A, Swindells S, et al. (2011) International randomized trial of immediate vs early ART in HIV+ patients treated for TB: ACTG 5221 STRIDE study. 18th Conference on Retroviruses and Opportunistic Infections, February 27-March 2, 2011, Boston, MA, USA. Abstract n. 38.
18. Velasco M, Castilla V, Sanz J, Gaspar G, Condes E, et al. (2009) Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. COMESEM Cohort. J Acquir Immune Defic Syndr 50 (2): 148-152.
19. Podlekareva DN, Mocroft A, Post FA, Riekstina V, Miro JM, et al. (2009) Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS 23 (18): 2485-2495.
20. Piggott DA, Karakousis PC, (2011) Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment. Clin Dev Immunol 2011: 103917.
21. Török ME, Yen NTB, Chau TTH, Mai NTH, Phu NH, et al. (2011) Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)- Associated Tuberculous Meningitis. Clin Infect Dis 52 (11): 1374-1383.
22. Soriano E, Mallolas J, Gatell JM, Latorre X, Miró JM, et al. (1988) Characteristics of tuberculosis in HIV-infected patients: a case-control study. AIDS 2 (6): 429-432.